GITNUXREPORT 2026

Autoimmune Disease Statistics

Autoimmune diseases affect millions of Americans and are both common and complex.

84 statistics5 sections7 min readUpdated 27 days ago

Key Statistics

Statistic 1

Over 75% of autoimmune disease patients are women, based on US registry data.

Statistic 2

Genetic factors contribute to 30% heritability in rheumatoid arthritis susceptibility.

Statistic 3

Smoking increases rheumatoid arthritis risk by 40% in current smokers versus never smokers.

Statistic 4

Family history doubles the risk of developing systemic lupus erythematosus.

Statistic 5

Vitamin D deficiency is associated with a 2-fold increased risk of multiple sclerosis.

Statistic 6

Obesity raises the risk of developing psoriasis by 20-50%.

Statistic 7

Epstein-Barr virus infection precedes 99% of multiple sclerosis cases.

Statistic 8

HLA-DR4 allele increases rheumatoid arthritis risk by 4-6 fold in certain populations.

Statistic 9

Female sex hormones like estrogen elevate autoimmune disease risk 4-10 times in women.

Statistic 10

Silica exposure increases systemic sclerosis risk by 3-fold.

Statistic 11

Gut microbiome dysbiosis is linked to 20-30% higher risk in IBD onset.

Statistic 12

Age of onset for type 1 diabetes peaks between 10-14 years, with 15% adult onset.

Statistic 13

African Americans have 3 times higher lupus prevalence than whites.

Statistic 14

Iodine intake correlates with 2-fold higher Hashimoto's thyroiditis incidence.

Statistic 15

Shift work disrupts circadian rhythms, increasing autoimmune risk by 25%.

Statistic 16

Alcohol consumption reduces rheumatoid arthritis risk by 30-50% in moderate drinkers.

Statistic 17

ANA test positivity in 95% of systemic lupus erythematosus cases.

Statistic 18

Rheumatoid factor positive in 70-80% of rheumatoid arthritis patients.

Statistic 19

MRI shows brain lesions in 95% of multiple sclerosis relapsing-remitting cases.

Statistic 20

Anti-CCP antibodies have 95% specificity for rheumatoid arthritis diagnosis.

Statistic 21

Endoscopy with biopsy confirms celiac disease in 90% with positive serology.

Statistic 22

Anti-TPO antibodies elevated in 90-95% of Hashimoto's thyroiditis.

Statistic 23

Oligoclonal bands in CSF found in 85-95% of multiple sclerosis patients.

Statistic 24

Calprotectin fecal test >250 μg/g indicates active IBD in 90% sensitivity.

Statistic 25

Schirmer's test <5mm wetting diagnoses dry eyes in Sjögren's with 85% accuracy.

Statistic 26

HLA-B27 positive in 90% of ankylosing spondylitis Caucasian patients.

Statistic 27

Acetylcholine receptor antibodies positive in 85% generalized myasthenia gravis.

Statistic 28

Anti-dsDNA antibodies correlate with lupus activity in 70% specificity.

Statistic 29

DEXA scan detects osteoporosis in 40% of long-term RA patients.

Statistic 30

Colonoscopy reveals ulcers in 95% active ulcerative colitis cases.

Statistic 31

Skin biopsy confirms psoriasis via epidermal hyperplasia in 98% cases.

Statistic 32

Autoimmune diseases affect approximately 50 million people in the United States, representing about 16% of the population and making them the third most common category of disease after cardiovascular and cancer diseases.

Statistic 33

Globally, autoimmune diseases impact over 5% of the population, with more than 80 distinct types identified.

Statistic 34

Rheumatoid arthritis has a worldwide prevalence of 0.5-1.0%, affecting about 1% of the global population.

Statistic 35

Systemic lupus erythematosus (SLE) prevalence ranges from 20 to 150 cases per 100,000 people worldwide.

Statistic 36

Multiple sclerosis affects approximately 2.8 million people worldwide, with a prevalence of 35.9 per 100,000.

Statistic 37

Type 1 diabetes incidence is rising globally at 2-5% per year, affecting about 8.4 million people worldwide.

Statistic 38

Celiac disease has a global prevalence of 1.4%, based on serologic testing in symptomatic populations.

Statistic 39

Hashimoto's thyroiditis accounts for 90% of autoimmune thyroid diseases, with prevalence up to 2% in women.

Statistic 40

Psoriasis affects 2-3% of the global population, with autoimmune mechanisms in plaque psoriasis.

Statistic 41

Inflammatory bowel disease (IBD) including Crohn's and ulcerative colitis affects 3 million Americans.

Statistic 42

Sjögren's syndrome prevalence is estimated at 0.5-1% of the adult population.

Statistic 43

Ankylosing spondylitis has a prevalence of 0.1-1.4% globally, higher in certain ethnic groups.

Statistic 44

Vitiligo affects 0.5-2% of the world's population.

Statistic 45

Myasthenia gravis incidence is 0.3-2.8 per million person-years.

Statistic 46

Autoimmune hepatitis prevalence is 10-20 per 100,000 in Europe and North America.

Statistic 47

Addison's disease has an incidence of 0.6 per 100,000 per year in white populations.

Statistic 48

Guillain-Barré syndrome annual incidence is 1-2 per 100,000 worldwide.

Statistic 49

In the US, autoimmune diseases cost over $100 billion annually in direct healthcare expenditures.

Statistic 50

Fatigue affects 80-90% of autoimmune disease patients as a primary symptom.

Statistic 51

Joint pain and swelling occur in 90% of rheumatoid arthritis cases within first year.

Statistic 52

Butterfly rash appears in 40-70% of systemic lupus erythematosus patients.

Statistic 53

Optic neuritis precedes multiple sclerosis diagnosis in 20-50% of cases.

Statistic 54

Abdominal pain and diarrhea affect 70% of inflammatory bowel disease patients.

Statistic 55

Dry eyes and mouth impact 95% of primary Sjögren's syndrome cases.

Statistic 56

Skin depigmentation in vitiligo covers 50% body surface in 10-20% severe cases.

Statistic 57

Muscle weakness peaks in myasthenia gravis, affecting ocular muscles in 85% initially.

Statistic 58

Hypothyroidism symptoms like weight gain occur in 60% of Hashimoto's patients.

Statistic 59

Psoriatic plaques cover >10% body surface in 20-30% of moderate-to-severe cases.

Statistic 60

Renal involvement in lupus nephritis affects 40-60% of SLE patients over time.

Statistic 61

Anemia is present in 50-75% of rheumatoid arthritis patients.

Statistic 62

Peripheral neuropathy complicates 20-30% of Sjögren's syndrome cases.

Statistic 63

Osteoporosis risk is 2-3 times higher in rheumatoid arthritis due to inflammation.

Statistic 64

Methotrexate achieves 50% ACR20 response in 40-60% RA patients at 6 months.

Statistic 65

Biologic DMARDs reduce rheumatoid arthritis radiographic progression by 70%.

Statistic 66

Hydroxychloroquine slows lupus progression by 50% in skin/musculoskeletal disease.

Statistic 67

Disease-modifying therapies like ocrelizumab reduce MS relapse rate by 46-68%.

Statistic 68

Gluten-free diet resolves symptoms in 70-90% newly diagnosed celiac patients.

Statistic 69

Levothyroxine normalizes TSH in 85% Hashimoto's patients within 6 months.

Statistic 70

Infliximab induces remission in 60% moderate-severe Crohn's disease at week 30.

Statistic 71

Rituximab depletes B-cells, achieving response in 60-70% refractory RA.

Statistic 72

Phototherapy clears 75% psoriasis lesions in 70% patients after 10 weeks.

Statistic 73

IVIG improves myasthenia gravis strength in 70-80% within 2 weeks.

Statistic 74

Mycophenolate mofetil stabilizes lupus nephritis in 60-70% at 6 months.

Statistic 75

TNF inhibitors halt ankylosing spondylitis progression in 50-70% BASDAI50 responders.

Statistic 76

Flares occur in 30-50% Sjögren's patients annually despite symptomatic treatment.

Statistic 77

Stem cell transplant induces 5-year remission in 70% severe scleroderma.

Statistic 78

Methotrexate monotherapy fails in 40% RA patients after 1 year, needing escalation.

Statistic 79

10-year mortality in rheumatoid arthritis is 50% higher than general population.

Statistic 80

Lupus patients have 2-10 fold increased cardiovascular mortality risk.

Statistic 81

Multiple sclerosis shortens life expectancy by 7-10 years on average.

Statistic 82

Celiac disease untreated raises lymphoma risk 6-fold.

Statistic 83

Hashimoto's increases cardiovascular disease risk by 40% if untreated.

Statistic 84

IBD raises colorectal cancer risk 2-fold after 8-10 years disease duration.

Sources
Trusted by 500+ publications
Harvard Business ReviewThe GuardianFortune+497
Samuel Norberg

Written by Samuel Norberg·Edited by Yumi Nakamura·Fact-checked by Nicholas Chambers

Published Feb 13, 2026·Last verified Apr 1, 2026
Fact-checked via 4-step process
01Primary Source Collection

Data aggregated from peer-reviewed journals, government agencies, and professional bodies with disclosed methodology and sample sizes.

02Editorial Curation

Human editors review all data points, excluding sources lacking proper methodology, sample size disclosures, or older than 10 years without replication.

03AI-Powered Verification

Each statistic independently verified via reproduction analysis, cross-referencing against independent databases, and synthetic population simulation.

04Human Cross-Check

Final human editorial review of all AI-verified statistics. Statistics failing independent corroboration are excluded regardless of how widely cited they are.

Read our full methodology →

Statistics that fail independent corroboration are excluded.

Imagine a health crisis silently affecting 50 million Americans—more than cancer and second only to heart disease—and you've just pictured the staggering, often invisible reality of autoimmune disease.

Key Takeaways

  • Autoimmune diseases affect approximately 50 million people in the United States, representing about 16% of the population and making them the third most common category of disease after cardiovascular and cancer diseases.
  • Globally, autoimmune diseases impact over 5% of the population, with more than 80 distinct types identified.
  • Rheumatoid arthritis has a worldwide prevalence of 0.5-1.0%, affecting about 1% of the global population.
  • Over 75% of autoimmune disease patients are women, based on US registry data.
  • Genetic factors contribute to 30% heritability in rheumatoid arthritis susceptibility.
  • Smoking increases rheumatoid arthritis risk by 40% in current smokers versus never smokers.
  • Fatigue affects 80-90% of autoimmune disease patients as a primary symptom.
  • Joint pain and swelling occur in 90% of rheumatoid arthritis cases within first year.
  • Butterfly rash appears in 40-70% of systemic lupus erythematosus patients.
  • ANA test positivity in 95% of systemic lupus erythematosus cases.
  • Rheumatoid factor positive in 70-80% of rheumatoid arthritis patients.
  • MRI shows brain lesions in 95% of multiple sclerosis relapsing-remitting cases.
  • Methotrexate achieves 50% ACR20 response in 40-60% RA patients at 6 months.
  • Biologic DMARDs reduce rheumatoid arthritis radiographic progression by 70%.
  • Hydroxychloroquine slows lupus progression by 50% in skin/musculoskeletal disease.

Autoimmune diseases affect millions of Americans and are both common and complex.

Demographics and Risk Factors

1Over 75% of autoimmune disease patients are women, based on US registry data.
Verified
2Genetic factors contribute to 30% heritability in rheumatoid arthritis susceptibility.
Verified
3Smoking increases rheumatoid arthritis risk by 40% in current smokers versus never smokers.
Single source
4Family history doubles the risk of developing systemic lupus erythematosus.
Verified
5Vitamin D deficiency is associated with a 2-fold increased risk of multiple sclerosis.
Verified
6Obesity raises the risk of developing psoriasis by 20-50%.
Verified
7Epstein-Barr virus infection precedes 99% of multiple sclerosis cases.
Verified
8HLA-DR4 allele increases rheumatoid arthritis risk by 4-6 fold in certain populations.
Verified
9Female sex hormones like estrogen elevate autoimmune disease risk 4-10 times in women.
Directional
10Silica exposure increases systemic sclerosis risk by 3-fold.
Directional
11Gut microbiome dysbiosis is linked to 20-30% higher risk in IBD onset.
Verified
12Age of onset for type 1 diabetes peaks between 10-14 years, with 15% adult onset.
Directional
13African Americans have 3 times higher lupus prevalence than whites.
Verified
14Iodine intake correlates with 2-fold higher Hashimoto's thyroiditis incidence.
Single source
15Shift work disrupts circadian rhythms, increasing autoimmune risk by 25%.
Directional
16Alcohol consumption reduces rheumatoid arthritis risk by 30-50% in moderate drinkers.
Verified

Demographics and Risk Factors Interpretation

Despite genetics loading the gun, it's a cocktail of gender, lifestyle, and environmental triggers—from shift work to silica, and even your gut bugs—that overwhelmingly pulls the trigger on autoimmune disease, while oddly, a modest drink might just loosen the grip.

Diagnosis and Testing

1ANA test positivity in 95% of systemic lupus erythematosus cases.
Verified
2Rheumatoid factor positive in 70-80% of rheumatoid arthritis patients.
Verified
3MRI shows brain lesions in 95% of multiple sclerosis relapsing-remitting cases.
Verified
4Anti-CCP antibodies have 95% specificity for rheumatoid arthritis diagnosis.
Verified
5Endoscopy with biopsy confirms celiac disease in 90% with positive serology.
Single source
6Anti-TPO antibodies elevated in 90-95% of Hashimoto's thyroiditis.
Verified
7Oligoclonal bands in CSF found in 85-95% of multiple sclerosis patients.
Single source
8Calprotectin fecal test >250 μg/g indicates active IBD in 90% sensitivity.
Single source
9Schirmer's test <5mm wetting diagnoses dry eyes in Sjögren's with 85% accuracy.
Single source
10HLA-B27 positive in 90% of ankylosing spondylitis Caucasian patients.
Verified
11Acetylcholine receptor antibodies positive in 85% generalized myasthenia gravis.
Verified
12Anti-dsDNA antibodies correlate with lupus activity in 70% specificity.
Verified
13DEXA scan detects osteoporosis in 40% of long-term RA patients.
Directional
14Colonoscopy reveals ulcers in 95% active ulcerative colitis cases.
Single source
15Skin biopsy confirms psoriasis via epidermal hyperplasia in 98% cases.
Directional

Diagnosis and Testing Interpretation

While our bodies often keep their treasonous plans well-hidden, modern medicine has become remarkably adept at uncovering these internal mutinies through a detective’s array of highly specific, if not quite universal, clues.

Prevalence and Incidence

1Autoimmune diseases affect approximately 50 million people in the United States, representing about 16% of the population and making them the third most common category of disease after cardiovascular and cancer diseases.
Verified
2Globally, autoimmune diseases impact over 5% of the population, with more than 80 distinct types identified.
Verified
3Rheumatoid arthritis has a worldwide prevalence of 0.5-1.0%, affecting about 1% of the global population.
Verified
4Systemic lupus erythematosus (SLE) prevalence ranges from 20 to 150 cases per 100,000 people worldwide.
Verified
5Multiple sclerosis affects approximately 2.8 million people worldwide, with a prevalence of 35.9 per 100,000.
Verified
6Type 1 diabetes incidence is rising globally at 2-5% per year, affecting about 8.4 million people worldwide.
Single source
7Celiac disease has a global prevalence of 1.4%, based on serologic testing in symptomatic populations.
Verified
8Hashimoto's thyroiditis accounts for 90% of autoimmune thyroid diseases, with prevalence up to 2% in women.
Verified
9Psoriasis affects 2-3% of the global population, with autoimmune mechanisms in plaque psoriasis.
Directional
10Inflammatory bowel disease (IBD) including Crohn's and ulcerative colitis affects 3 million Americans.
Verified
11Sjögren's syndrome prevalence is estimated at 0.5-1% of the adult population.
Verified
12Ankylosing spondylitis has a prevalence of 0.1-1.4% globally, higher in certain ethnic groups.
Verified
13Vitiligo affects 0.5-2% of the world's population.
Single source
14Myasthenia gravis incidence is 0.3-2.8 per million person-years.
Verified
15Autoimmune hepatitis prevalence is 10-20 per 100,000 in Europe and North America.
Single source
16Addison's disease has an incidence of 0.6 per 100,000 per year in white populations.
Verified
17Guillain-Barré syndrome annual incidence is 1-2 per 100,000 worldwide.
Verified
18In the US, autoimmune diseases cost over $100 billion annually in direct healthcare expenditures.
Verified

Prevalence and Incidence Interpretation

While collectively these disorders form a massive, costly, and under-recognized third pillar of human illness behind heart disease and cancer, the sobering truth is that for the millions living with them, autoimmune disease is a deeply personal war where the body's own defenses have tragically gone rogue.

Symptoms and Complications

1Fatigue affects 80-90% of autoimmune disease patients as a primary symptom.
Single source
2Joint pain and swelling occur in 90% of rheumatoid arthritis cases within first year.
Verified
3Butterfly rash appears in 40-70% of systemic lupus erythematosus patients.
Verified
4Optic neuritis precedes multiple sclerosis diagnosis in 20-50% of cases.
Single source
5Abdominal pain and diarrhea affect 70% of inflammatory bowel disease patients.
Verified
6Dry eyes and mouth impact 95% of primary Sjögren's syndrome cases.
Verified
7Skin depigmentation in vitiligo covers 50% body surface in 10-20% severe cases.
Verified
8Muscle weakness peaks in myasthenia gravis, affecting ocular muscles in 85% initially.
Verified
9Hypothyroidism symptoms like weight gain occur in 60% of Hashimoto's patients.
Verified
10Psoriatic plaques cover >10% body surface in 20-30% of moderate-to-severe cases.
Verified
11Renal involvement in lupus nephritis affects 40-60% of SLE patients over time.
Verified
12Anemia is present in 50-75% of rheumatoid arthritis patients.
Verified
13Peripheral neuropathy complicates 20-30% of Sjögren's syndrome cases.
Verified
14Osteoporosis risk is 2-3 times higher in rheumatoid arthritis due to inflammation.
Single source

Symptoms and Complications Interpretation

While autoimmune diseases may specialize in different body parts, their shared talent for turning a patient’s own systems against them ensures that whether it's crippling fatigue, a betraying rash, or a rebellious joint, the theme is always a profound and unwelcome civil war within.

Treatment Management and Outcomes

1Methotrexate achieves 50% ACR20 response in 40-60% RA patients at 6 months.
Verified
2Biologic DMARDs reduce rheumatoid arthritis radiographic progression by 70%.
Directional
3Hydroxychloroquine slows lupus progression by 50% in skin/musculoskeletal disease.
Single source
4Disease-modifying therapies like ocrelizumab reduce MS relapse rate by 46-68%.
Verified
5Gluten-free diet resolves symptoms in 70-90% newly diagnosed celiac patients.
Verified
6Levothyroxine normalizes TSH in 85% Hashimoto's patients within 6 months.
Verified
7Infliximab induces remission in 60% moderate-severe Crohn's disease at week 30.
Verified
8Rituximab depletes B-cells, achieving response in 60-70% refractory RA.
Verified
9Phototherapy clears 75% psoriasis lesions in 70% patients after 10 weeks.
Verified
10IVIG improves myasthenia gravis strength in 70-80% within 2 weeks.
Verified
11Mycophenolate mofetil stabilizes lupus nephritis in 60-70% at 6 months.
Verified
12TNF inhibitors halt ankylosing spondylitis progression in 50-70% BASDAI50 responders.
Single source
13Flares occur in 30-50% Sjögren's patients annually despite symptomatic treatment.
Verified
14Stem cell transplant induces 5-year remission in 70% severe scleroderma.
Verified
15Methotrexate monotherapy fails in 40% RA patients after 1 year, needing escalation.
Verified
1610-year mortality in rheumatoid arthritis is 50% higher than general population.
Single source
17Lupus patients have 2-10 fold increased cardiovascular mortality risk.
Verified
18Multiple sclerosis shortens life expectancy by 7-10 years on average.
Single source
19Celiac disease untreated raises lymphoma risk 6-fold.
Verified
20Hashimoto's increases cardiovascular disease risk by 40% if untreated.
Verified
21IBD raises colorectal cancer risk 2-fold after 8-10 years disease duration.
Verified

Treatment Management and Outcomes Interpretation

Modern medicine is winning a series of hard-fought, percentage-point skirmishes, but the sobering statistics remind us we're still losing the broader war against the systemic toll these diseases take.

How We Rate Confidence

Models

Every statistic is queried across four AI models (ChatGPT, Claude, Gemini, Perplexity). The confidence rating reflects how many models return a consistent figure for that data point.

Single source
ChatGPTClaudeGeminiPerplexity

Only one AI model returns this statistic from its training data. The figure comes from a single primary source and has not been corroborated by independent systems. Use with caution; cross-reference before citing.

AI consensus: 1 of 4 models agree

Directional
ChatGPTClaudeGeminiPerplexity

Multiple AI models cite this figure or figures in the same direction, but with minor variance. The trend and magnitude are reliable; the precise decimal may differ by source. Suitable for directional analysis.

AI consensus: 2–3 of 4 models broadly agree

Verified
ChatGPTClaudeGeminiPerplexity

All AI models independently return the same statistic, unprompted. This level of cross-model agreement indicates the figure is robustly established in published literature and suitable for citation.

AI consensus: 4 of 4 models fully agree

Models

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, February 13). Autoimmune Disease Statistics. Gitnux. https://gitnux.org/autoimmune-disease-statistics
MLA
Samuel Norberg. "Autoimmune Disease Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/autoimmune-disease-statistics.
Chicago
Samuel Norberg. 2026. "Autoimmune Disease Statistics." Gitnux. https://gitnux.org/autoimmune-disease-statistics.

Sources & References

Logos provided by Logo.dev